Literature DB >> 6846063

Studies on high density lipoproteins in fish eye disease.

L A Carlson, L Holmquist.   

Abstract

Serum high density lipoproteins (HDL) were isolated by preparative ultracentrifugation from two patients with fish eye disease (FED). Compared to HDL from control subjects the HDL particles of FED were characterized by their abnormally small size and a relative enrichment with polar lipids. No qualitative abnormalities of the HDL apolipoproteins were revealed upon polyacrylamide disc gel electrophoresis or isoelectric focusing. The plasma pool of apolipoprotein A was reduced by 90%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6846063     DOI: 10.1111/j.0954-6820.1983.tb03713.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Normalization of high density lipoprotein in fish eye disease plasma by purified normal human lecithin: cholesterol acyltransferase.

Authors:  L Holmquist; L A Carlson
Journal:  Lipids       Date:  1988-03       Impact factor: 1.880

2.  Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).

Authors:  H G Klein; P Lohse; P H Pritchard; D Bojanovski; H Schmidt; H B Brewer
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 4.  Familial LCAT deficiency and fish-eye disease.

Authors:  N McIntyre
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Net lipid transfer between lipoproteins in fish-eye disease plasma supplemented with normal high density lipoproteins.

Authors:  L Holmquist; L A Carlson
Journal:  Lipids       Date:  1987-05       Impact factor: 1.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.